Amarin Corp Plc (AMRN)

[HDGabor]

No problem.

I never said the my assumption for the calculation will be always correct. I used ie.:
- the Total Operating Expenses as Q2 (no additional decrease)
- GM% also as Q2 (60,14%), since as the first time it was lower than the previous period (Q1 2014). Meanwhile I hope it will be higher.

With my assumption, parameters (Based on Q2 2014):

Net revenue / script: $134,67
GM%: 60,14%
KOWA fee: 9% of Gross Margin
BioPharma: 10% of Net Revenue
Total Operating Expenses: as Q2
Notes interest: 3,5%
One-time expenses (ie.: $8.5 million license fee of ANCHOR to Laxdale) excluded

the break even script number (40,233 / week) is correct. If they could increase the GM% and / or decrease the OPEX (I do not think they could significantly increase the Net revenue / script) the break even script number will be less.